{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T03:57:48Z","timestamp":1785556668547,"version":"3.56.0"},"reference-count":46,"publisher":"American Psychiatric Association Publishing","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP"],"published-print":{"date-parts":[[2002,8,1]]},"DOI":"10.1176\/appi.ajp.159.8.1337","type":"journal-article","created":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T21:39:33Z","timestamp":1033508373000},"page":"1337-1346","source":"Crossref","is-referenced-by-count":390,"title":["Double-Blind, Placebo-Controlled Study of Risperidone for the Treatment of Disruptive Behaviors in Children With Subaverage Intelligence"],"prefix":"10.1176","volume":"159","author":[{"given":"Michael G.","family":"Aman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goedele","family":"De Smedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Derivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Lyons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Findling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Risperidone Disruptive Behavior Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"230","reference":[{"key":"R1598CHDFHCAJ","doi-asserted-by":"crossref","unstructured":"Campbell M, Gonzalez NM, Silva RR: The pharmacological treatment of conduct disorders and rage outbursts. Psychiatr Clin North Am 1992; 15:69-85","DOI":"10.1016\/S0193-953X(18)30258-2"},{"key":"R1598CHDCJAAI","doi-asserted-by":"crossref","unstructured":"Scott S: Aggressive behaviour in childhood. Br Med J 1998; 316:202-206","DOI":"10.1136\/bmj.316.7126.202"},{"key":"R1598CHDHBGJA","doi-asserted-by":"crossref","unstructured":"Campbell M, Malone RP: Mental retardation and psychiatric disorders. Hosp Community Psychiatry 1991; 42:374-379","DOI":"10.1176\/ps.42.4.374"},{"key":"atypb1","doi-asserted-by":"crossref","unstructured":"Lovell RW, Reiss AL: Dual diagnoses: psychiatric disorders in developmental disabilities. Pediatr Clin North Am 1993; 40:579-592","DOI":"10.1016\/S0031-3955(16)38552-2"},{"key":"atypb2","doi-asserted-by":"crossref","unstructured":"Moss S, Emerson E, Bouras N, Holland A: Mental disorders and problematic behaviours in people with intellectual disability: future directions for research. J Intellect Disabil Res 1997; 41:440-447","DOI":"10.1111\/j.1365-2788.1997.tb00735.x"},{"key":"atypb3","unstructured":"Schaal DW, Hackenberg T: Toward a functional analysis of drug treatment for behavior problems of people with developmental disabilities. Am J Ment Retard 1994; 99:123-140"},{"key":"R1598CHDFJHAE","doi-asserted-by":"crossref","unstructured":"Santosh PJ, Baird G: Psychopharmacotherapy in children and adults with intellectual disability. Lancet 1999; 354:233-242","DOI":"10.1016\/S0140-6736(98)07059-7"},{"key":"R1598XXX","doi-asserted-by":"crossref","unstructured":"Lavin MR, Rifkin A: Diagnosis and pharmacotherapy of conduct disorder. Prog Neuropsychopharmacol Biol Psychiatry 1993; 17:875-885","DOI":"10.1016\/0278-5846(93)90017-M"},{"key":"R1598CHDCFBBD","doi-asserted-by":"crossref","unstructured":"Werry JS: Severe conduct disorder\u2014some key issues. Can J Psychiatry 1997; 42:577-583","DOI":"10.1177\/070674379704200603"},{"key":"R1598XXXC","doi-asserted-by":"crossref","unstructured":"Moretti MM, Emmrys C, Grizenko N, Holland R, Moore K, Shamsie J, Hamilton H: The treatment of conduct disorder: perspectives from across Canada. Can J Psychiatry 1997; 42:637-648","DOI":"10.1177\/070674379704200611"},{"key":"R1598XXXD","doi-asserted-by":"crossref","unstructured":"Brestan EV, Eyberg SM: Effective psychosocial treatments of conduct-disordered children and adolescents: 29 years, 82 studies, and 5,272 kids. J Clin Child Psychol 1998; 27:180-189","DOI":"10.1207\/s15374424jccp2702_5"},{"key":"R1598CHDCCHGG","doi-asserted-by":"crossref","unstructured":"Findling RL, McNamara NK, Branicky LA, Schluchter MD, Lemon E, Blumer JL: A double-blind pilot study of risperidone in the treatment of conduct disorder. J Am Acad Child Adolesc Psychiatry 2000; 39:509-516","DOI":"10.1097\/00004583-200004000-00021"},{"key":"R1598CHDFFGDJ","doi-asserted-by":"crossref","unstructured":"Van Bellinghen M, De Troch C: Risperidone in the treatment of behavioral disturbances in children and adolescents with borderline intellectual functioning: a double-blind, placebo-controlled pilot trial. J Child Adolesc Psychopharmacol 2001; 11:5-13","DOI":"10.1089\/104454601750143348"},{"key":"R1598CHDCEAGA","doi-asserted-by":"crossref","unstructured":"Buitelaar JK, van der Gaag, RJ, Cohen-Kettenis P, Melman CTM: A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities. J Clin Psychiatry 2001; 62:239-248","DOI":"10.4088\/JCP.v62n0405"},{"key":"R1598CHDIJFED","doi-asserted-by":"crossref","unstructured":"Kewley GD: Risperidone in comorbid ADHD and ODD\/CD. J Am Acad Child Adolesc Psychiatry 1999; 38:1327-1328","DOI":"10.1097\/00004583-199911000-00002"},{"key":"atypb4","doi-asserted-by":"crossref","unstructured":"Hardan A, Johnson K, Johnson C, Hrecznyj B: Case study: risperidone treatment of children and adolescents with developmental disorders. J Am Acad Child Adolesc Psychiatry 1996; 35:1551-1556","DOI":"10.1097\/00004583-199611000-00025"},{"key":"atypb5","doi-asserted-by":"crossref","unstructured":"Fras I, Major LF: Clinical experience with risperidone (letter). J Am Acad Child Adolesc Psychiatry 1995; 34:833","DOI":"10.1097\/00004583-199507000-00003"},{"key":"atypb6","doi-asserted-by":"crossref","unstructured":"Carroll NB, Boehm KE, Strickland RT: Chorea and tardive dyskinesia in a patient taking risperidone. J Clin Psychiatry 1999; 60:485-487","DOI":"10.4088\/JCP.v60n0711b"},{"key":"atypb7","unstructured":"Kleinsasser BJ, Misra LK, Bhatara VS, Sanchez JD: Risperidone in the treatment of choreiform movements and aggressiveness in a child with \u201cPANDAS.\u201d SD J Med 1999; 52:345-347"},{"key":"atypb8","doi-asserted-by":"crossref","unstructured":"Schreier HA: Risperidone for young children with mood disorders and aggressive behavior. J Child Adolesc Psychopharmacol 1998; 8:49-59","DOI":"10.1089\/cap.1998.8.49"},{"key":"atypb9","doi-asserted-by":"crossref","unstructured":"Simeon JG, Carrey NJ, Wiggins DM, Milin RP, Hosenbocus SN: Risperidone effects in treatment-resistant adolescents: preliminary case reports. J Child Adolesc Psychopharmacol 1995; 5:69-79","DOI":"10.1089\/cap.1995.5.69"},{"key":"atypb10","doi-asserted-by":"crossref","unstructured":"Posey DJ, Walsh KH, Wilson GA, McDougle CJ: Risperidone in the treatment of two very young children with autism. J Child Adolesc Psychopharmacol 1999; 9:273-276","DOI":"10.1089\/cap.1999.9.273"},{"key":"atypb11","doi-asserted-by":"crossref","unstructured":"Horrigan JP, Sikich L: Diet and the atypical neuroleptics. J Am Acad Child Adolesc Psychiatry 1998; 37:1126-1127","DOI":"10.1097\/00004583-199811000-00003"},{"key":"atypb12","doi-asserted-by":"crossref","unstructured":"Frischauf E: Drug therapy in autism (letter). J Am Acad Child Adolesc Psychiatry 1997; 36:577","DOI":"10.1097\/00004583-199705000-00004"},{"key":"atypb13","doi-asserted-by":"crossref","unstructured":"McDougle CJ, Holmes JP, Bronson MR, Anderson GM, Volkmar FR, Price LH, Cohen DJ: Risperidone treatment of children and adolescents with pervasive developmental disorders: a prospective, open-label study. J Am Acad Child Adolesc Psychiatry 1997; 36:683-693","DOI":"10.1097\/00004583-199705000-00020"},{"key":"atypb14","doi-asserted-by":"crossref","unstructured":"Demb H: Risperidone in young children with pervasive developmental disorders and other developmental disabilities. J Child Adolesc Psychopharmacol 1996; 6:79-80","DOI":"10.1089\/cap.1996.6.79"},{"key":"atypb15","doi-asserted-by":"crossref","unstructured":"Fisman S, Steele M, Short J, Byrne T, Lavallee C: Case study: anorexia nervosa and autistic disorder in an adolescent girl. J Am Acad Child Adolesc Psychiatry 1996; 35:937-940","DOI":"10.1097\/00004583-199607000-00021"},{"key":"atypb16","doi-asserted-by":"crossref","unstructured":"Fisman S, Steele M: Use of risperidone in pervasive development disorders: a case series. J Child Adolesc Psychopharmacol 1996; 6:177-190","DOI":"10.1089\/cap.1996.6.177"},{"key":"atypb17","doi-asserted-by":"crossref","unstructured":"Fitzgerald KD, Stewart CM, Tawile V, Rosenberg DR: Risperidone augmentation of serotonin reuptake inhibitor treatment of pediatric obsessive compulsive disorder. J Child Adolesc Psychopharmacol 1999; 9:115-123","DOI":"10.1089\/cap.1999.9.115"},{"key":"atypb18","doi-asserted-by":"crossref","unstructured":"Frazier JA, Meyer MC, Biederman J, Wozniak J, Wilens TE, Spencer TJ, Kim GS, Shapiro S: Risperidone treatment for juvenile bipolar disorder: a retrospective chart review. J Am Acad Child Adolesc Psychiatry 1999; 38:960-965","DOI":"10.1097\/00004583-199908000-00011"},{"key":"atypb19","unstructured":"Findling RL, Maxwell K, Wiznitzer M: An open clinical trial of risperidone monotherapy in young children with autistic disorder. Psychopharmacol Bull 1997; 33:155-159"},{"key":"atypb20","doi-asserted-by":"crossref","unstructured":"Vanden Borre R, Vermote R, Buttiens M, Thiry P, Dierick G, Geutjens J, Sieben G, Heylen S: Risperidone as add-on therapy in behavioural disturbances in mental retardation: a double-blind placebo-controlled cross-over study. Acta Psychiatr Scand 1993; 87:167-171","DOI":"10.1111\/j.1600-0447.1993.tb03350.x"},{"key":"atypb21","doi-asserted-by":"crossref","unstructured":"Nicolson R, Awad G, Sloman L: An open trial of risperidone in young autistic children. J Am Acad Child Adolesc Psychiatry 1998; 37:372-376","DOI":"10.1097\/00004583-199804000-00014"},{"key":"R1598CHDDGIAB","doi-asserted-by":"crossref","unstructured":"Horrigan JP, Barnhill LJ: Risperidone and explosive aggressive autism. J Autism Dev Disord 1997; 27:313-323","DOI":"10.1023\/A:1025854532079"},{"key":"atypb22","unstructured":"Simon EW, Blubaugh KM, Pippidis M: Substituting traditional antipsychotics with risperidone for individuals with mental retardation. Ment Retard 1996; 34:359-366"},{"key":"atypb23","unstructured":"Khan BU: Brief report: risperidone for severely disturbed behavior and tardive dyskinesia in developmentally disabled adults. J Autism Dev Disord 1997; 27:479-489"},{"key":"atypb24","doi-asserted-by":"crossref","unstructured":"Cohen SA, Ihrig K, Lott RS, Kerrick JM: Risperidone for aggression and self-injurious behavior in adults with mental retardation. J Autism Dev Disord 1998; 28:229-233","DOI":"10.1023\/A:1026069421988"},{"key":"atypb25","unstructured":"Lott RS, Kerrick JM, Cohen SA: Clinical and economic aspects of risperidone treatment in adults with mental retardation and behavioral disturbance. Psychopharmacol Bull 1996; 32:721-729"},{"key":"R1598XXXG","doi-asserted-by":"crossref","unstructured":"Dartnall NA, Holmes JP, Morgan SN, McDougle CJ: Brief report: two-year control of behavioral symptoms with risperidone in two profoundly retarded adults with autism. J Autism Dev Disord 1999; 29:87-91","DOI":"10.1023\/A:1025926817928"},{"key":"R1598CHDEICHI","doi-asserted-by":"crossref","unstructured":"Tass\u00e9 MJ, Aman MG, Hammer D, Rojahn J: The Nisonger Child Behavior Rating Form: age and gender effect and norms. Res Dev Disabil 1996; 17:59-75","DOI":"10.1016\/0891-4222(95)00037-2"},{"key":"R1598CHDFJGIE","doi-asserted-by":"crossref","unstructured":"Aman MG, Tass\u00e9 MJ, Rojahn J, Hammer D: The Nisonger CBRF: a child behavior rating form for children with developmental disabilities. Res Dev Disabil 1996; 17:41-57","DOI":"10.1016\/0891-4222(95)00039-9"},{"key":"R1598CHDGHAEC","doi-asserted-by":"crossref","unstructured":"Aman MG, Singh NN, Stewart AW, Field CJ: The Aberrant Behavior Checklist: a behavior rating scale for the assessment of treatment effects. Am J Ment Defic 1985; 89:485-491","DOI":"10.1037\/t10453-000"},{"key":"R1598CHDEGIJD","doi-asserted-by":"crossref","unstructured":"Rojahn J, Matson JL, Lot D, Esbensen AJ, Smalls Y: The Behavior Problems Inventory: an instrument for the assessment of self-injury, stereotyped behavior, and aggression\/destruction in individuals with developmental disabilities. J Autism Dev Disord 2001; 31:577-588","DOI":"10.1023\/A:1013299028321"},{"key":"R1598CHDHGFEA","unstructured":"Chouinard G, Ross-Chouinard A, Annable L, Jones B: Extrapyramidal Symptom Rating Scale (abstract). Can J Neurol Sci 1980; 7:233"},{"key":"R1598CHDBCEBH","unstructured":"Platt JE, Campbell M, Grega DM, Green WH: Cognitive effects of haloperidol and lithium in aggressive conduct-disorder children. Psychopharmacol Bull 1984; 20:93-97"},{"key":"R1598CHDEIADI","doi-asserted-by":"crossref","unstructured":"Taylor DM, McAskill R: Atypical antipsychotics and weight gain\u2014a systematic review. Acta Psychiatr Scand 2000; 101:416-432","DOI":"10.1034\/j.1600-0447.2000.101006416.x"}],"container-title":["American Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.159.8.1337","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T14:13:14Z","timestamp":1722175994000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.159.8.1337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8,1]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2002,8,1]]}},"alternative-id":["10.1176\/appi.ajp.159.8.1337"],"URL":"https:\/\/doi.org\/10.1176\/appi.ajp.159.8.1337","relation":{},"ISSN":["0002-953X","1535-7228"],"issn-type":[{"value":"0002-953X","type":"print"},{"value":"1535-7228","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,8,1]]}}}